Astrocyte-Neuron Metabolic Coupling Titration

Target: BDH1 Composite Score: 0.704 Price: $0.70▲11.5% Citation Quality: Pending metabolic neuroscience Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

✓ All Quality Gates Passed

Quality Report Card click to collapse

B+

Composite: 0.704

Top 26% of 984 hypotheses

T2 Supported

Literature-backed with debate validation

Needs convergence ≥0.40 (current: 0.00) for Established

B Mech. Plausibility 15% 0.60 Top 60%

C+ Evidence Strength 15% 0.50 Top 67%

B+ Novelty 12% 0.70 Top 56%

C+ Feasibility 12% 0.50 Top 62%

B+ Impact 12% 0.70 Top 45%

C+ Druggability 10% 0.50 Top 63%

C+ Safety Profile 8% 0.50 Top 58%

B Competition 6% 0.60 Top 63%

B Data Availability 5% 0.60 Top 51%

C+ Reproducibility 5% 0.50 Top 68%

Evidence

3 supporting | 2 opposing

Citation quality: 0%

Debates

1 session A

Avg quality: 0.80

Convergence

0.00 F 7 related hypothesis share this target

From Analysis:

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection?

While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and how much ketosis provides benefit vs harm. The 'metabolic steal syndrome' hypothesis suggests timing could be critical but remains untested. Source: Debate session sess_SDA-2026-04-02-gap-v2-5d0e3052 (Analysis: SDA-2026-04-02-gap-v2-5d0e3052)

→ View full analysis & debate transcript

Hypotheses from Same Analysis (7)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Epigenetic Priming Ketone Protocol

Score: 0.882 | Target: HDAC2/HDAC3

Biphasic Ketogenic Intervention Protocol

Score: 0.773 | Target: HMGCS2

Inflammatory State-Dependent Ketone Timing

Score: 0.647 | Target: IRAKM

Circadian-Gated Ketone Window Hypothesis

Score: 0.606 | Target: OXCT1

Circadian Epigenetic Ketone Synchronization Protocol

Score: 0.543 | Target: CLOCK/BMAL1

Glucose-Ketone Metabolic Switch Timing

Score: 0.531 | Target: GLUT1/GLUT3/MCT1/MCT2

Age-Stratified Ketone Dosing Matrix

Score: 0.452 | Target: OXCT1

→ View full analysis & all 8 hypotheses

Description

β-hydroxybutyrate strongly inhibits astrocytic glucose consumption and blunts glycolytic stimulation in astrocytes (PMID: 26661221), while substrate competition studies indicate that cortical astrocytes retain flexibility to oxidize multiple substrates including ketones (PMID: 23079895). The inhibition of astrocytic glycolysis parallels increased mitochondrial pyruvate metabolism (PMID: 26661221), suggesting metabolic remasking rather than complete substrate switching. The net effect on astrocyte-neuron lactate shuttle dynamics and whether a "metabolic steal syndrome" occurs at higher concentrations remains unresolved.

...

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

5 citations 5 with PMID Validation: 0% 3 supporting / 2 opposing

✓ For (3)

No supporting evidence

No opposing evidence

(2) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 4CLIN 1GENE 0EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
β-hydroxybutyrate strongly inhibits astrocytic glu…	Supporting	MECH	-	-	-	-	PMID:26661221	-
Substrate competition studies show cortical astroc…	Supporting	MECH	-	-	-	-	PMID:23079895	-
The inhibition of astrocytic glycolysis parallels …	Supporting	MECH	-	-	-	-	PMID:26661221	-
Studies on ketone toxicity show that even high dos…	Opposing	CLIN	-	-	-	-	PMID:22561291	-
BDH1 overexpression alleviates diabetic cardiomyop…	Opposing	MECH	Cardiovasc Diab…	-	2025	-	PMID:40022118	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 3

β-hydroxybutyrate strongly inhibits astrocytic glucose consumption and blunts glycolytic stimulation

PMID:26661221

Substrate competition studies show cortical astrocytes can oxidize multiple substrates including ketones

PMID:23079895

The inhibition of astrocytic glycolysis parallels increased mitochondrial pyruvate metabolism

PMID:26661221

✗ Opposing Evidence 2

Studies on ketone toxicity show that even high doses of ketone esters are well-tolerated in healthy adults, su…▼

Studies on ketone toxicity show that even high doses of ketone esters are well-tolerated in healthy adults, suggesting the proposed toxicity thresholds may be incorrect

PMID:22561291

BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional act…▼

BDH1 overexpression alleviates diabetic cardiomyopathy through inhibiting H3K9bhb-mediated transcriptional activation of LCN2.

Cardiovasc Diabetol · 2025 · PMID:40022118

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-03 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Based on my research into ketone metabolism, neuroprotection, and the metabolic steal syndrome hypothesis, I'll generate novel therapeutic hypotheses for optimal timing and dosing of ketogenic interventions.

Novel Therapeutic Hypotheses for Ketogenic Neuroprotection

1. Circadian-Gated Ketone Window Hypothesis

Description: Ketone body utilization efficiency follows circadian rhythms, with optimal neuroprotective windows occurring during natural fasting periods (18:00-06:00). β-hydroxybutyrate administered during these periods maximizes mitochondrial efficiency while minimizing

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Based on my analysis of the available research, here is my critical evaluation of each hypothesis:

Critical Analysis of Ketogenic Neuroprotection Hypotheses

1. Circadian-Gated Ketone Window Hypothesis

Specific Weaknesses:

The PMID:17126577 citation is vague and doesn't specifically support circadian variations in OXCT1 expression or ketone utilization efficiency
No direct evidence provided for the claimed 18:00-06:00 optimal window
Assumption that circadian energy metabolism variations translate to ketone-specific therapeutic windows is unsubstantiated

**Counter-Eviden

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Druggability Assessment for Ketogenic Neuroprotection Hypotheses

Based on my analysis of the target proteins and therapeutic landscape, here's a comprehensive assessment of the practical feasibility for each surviving hypothesis:

1. Circadian-Gated Ketone Window Hypothesis (Target: OXCT1)

Revised Confidence: 0.35

Druggability Assessment

POOR DRUGGABILITY - OXCT1 is a mitochondrial matrix enzyme that catalyzes CoA transfer reactions. The active site is highly conserved and essential for cellular metabolism, making selective modulation extremely challenging without disrupting

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

Price History

7d Trend

↔

Stable

7d Momentum

▲ 11.5%

Volatility

Low

0.0096

Events (7d)

⚡ Price Movement Log Recent 9 events

	Event	Price	Change	Source	Time
💬	Debate Round	$0.854	▲ 53.5%	market_dynamics	2026-04-17 07:07
📊	Score Update	$0.556	▼ 2.0%	market_dynamics	2026-04-17 04:54
📄	New Evidence	$0.568	▼ 3.5%	market_dynamics	2026-04-17 03:48
📄	New Evidence	$0.588	▲ 1.3%	market_dynamics	2026-04-17 03:01
📄	New Evidence	$0.581	▲ 11.6%	market_dynamics	2026-04-17 02:53
💬	Debate Round	$0.520	▲ 1.1%	market_dynamics	2026-04-17 01:36
💬	Debate Round	$0.515	▼ 11.9%	market_dynamics	2026-04-17 00:46
📊	Score Update	$0.584	▼ 13.0%	market_dynamics	2026-04-17 00:10
📊	Score Update	$0.671		market_dynamics	2026-04-16 23:39

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (4)

Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects.

Regulatory toxicology and pharmacology : RTP (2012) · PMID:22561291

No extracted figures yet

Substrate competition studies demonstrate oxidative metabolism of glucose, glutamate, glutamine, lactate and 3-hydroxybutyrate in cortical astrocytes from rat brain.

Neurochemical research (2013) · PMID:23079895

No extracted figures yet

Targeting of astrocytic glucose metabolism by beta-hydroxybutyrate.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2017) · PMID:26661221

No extracted figures yet

Paper:40022118

No extracted figures yet

📓 Linked Notebooks (1)

📓 What determines the optimal timing and dosing of ketogenic interventions for neuroprotection? - Analysis Notebook

CI-generated notebook stub for analysis SDA-2026-04-03-gap-debate-20260403-222618-2709aad9. While ketone metabolism was discussed as therapeutic, the debate revealed no clear framework for when and ho …

→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

→ Browse all arenas & tournaments

KG Entities (14)

BDH1 GLUT1/GLUT3/MCT1/MCT2 HDAC2/HDAC3 HMGCS2 IRAKM OXCT1 h-17a2da3f h-404bab00 h-6df1bc66 h-9d4571a7 h-a1d97415 h-a947032c h-d7212534 metabolic_neuroscience

Related Hypotheses

Epigenetic Priming Ketone Protocol

Score: 0.882 | metabolic neuroscience

Biphasic Ketogenic Intervention Protocol

Score: 0.773 | metabolic neuroscience

Inflammatory State-Dependent Ketone Timing

Score: 0.647 | metabolic neuroscience

Circadian-Gated Ketone Window Hypothesis

Score: 0.606 | metabolic neuroscience

Circadian Epigenetic Ketone Synchronization Protocol

Score: 0.543 | metabolic neuroscience

Estimated Development

Estimated Cost

Timeline

0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (13 edges)

associated with (6)

HDAC2/HDAC3 → metabolic_neuroscience

HMGCS2 → metabolic_neuroscience

BDH1 → metabolic_neuroscience

IRAKM → metabolic_neuroscience

OXCT1 → metabolic_neuroscience

...and 1 more

targets (7)

h-d7212534 → HDAC2/HDAC3

h-6df1bc66 → HMGCS2

h-17a2da3f → BDH1

h-a1d97415 → IRAKM

h-9d4571a7 → OXCT1

...and 2 more

Mechanism Pathway for BDH1

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    h_d7212534["h-d7212534"] -->|targets| HDAC2_HDAC3["HDAC2/HDAC3"]
    h_6df1bc66["h-6df1bc66"] -->|targets| HMGCS2["HMGCS2"]
    h_17a2da3f["h-17a2da3f"] -->|targets| BDH1["BDH1"]
    h_a1d97415["h-a1d97415"] -->|targets| IRAKM["IRAKM"]
    h_9d4571a7["h-9d4571a7"] -->|targets| OXCT1["OXCT1"]
    h_a947032c["h-a947032c"] -->|targets| GLUT1_GLUT3_MCT1_MCT2["GLUT1/GLUT3/MCT1/MCT2"]
    h_404bab00["h-404bab00"] -->|targets| OXCT1_1["OXCT1"]
    HDAC2_HDAC3_2["HDAC2/HDAC3"] -->|associated with| metabolic_neuroscience["metabolic_neuroscience"]
    HMGCS2_3["HMGCS2"] -->|associated with| metabolic_neuroscience_4["metabolic_neuroscience"]
    BDH1_5["BDH1"] -->|associated with| metabolic_neuroscience_6["metabolic_neuroscience"]
    IRAKM_7["IRAKM"] -->|associated with| metabolic_neuroscience_8["metabolic_neuroscience"]
    OXCT1_9["OXCT1"] -->|associated with| metabolic_neuroscience_10["metabolic_neuroscience"]
    style h_d7212534 fill:#4fc3f7,stroke:#333,color:#000
    style HDAC2_HDAC3 fill:#ce93d8,stroke:#333,color:#000
    style h_6df1bc66 fill:#4fc3f7,stroke:#333,color:#000
    style HMGCS2 fill:#ce93d8,stroke:#333,color:#000
    style h_17a2da3f fill:#4fc3f7,stroke:#333,color:#000
    style BDH1 fill:#ce93d8,stroke:#333,color:#000
    style h_a1d97415 fill:#4fc3f7,stroke:#333,color:#000
    style IRAKM fill:#ce93d8,stroke:#333,color:#000
    style h_9d4571a7 fill:#4fc3f7,stroke:#333,color:#000
    style OXCT1 fill:#ce93d8,stroke:#333,color:#000
    style h_a947032c fill:#4fc3f7,stroke:#333,color:#000
    style GLUT1_GLUT3_MCT1_MCT2 fill:#ce93d8,stroke:#333,color:#000
    style h_404bab00 fill:#4fc3f7,stroke:#333,color:#000
    style OXCT1_1 fill:#ce93d8,stroke:#333,color:#000
    style HDAC2_HDAC3_2 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience fill:#ef5350,stroke:#333,color:#000
    style HMGCS2_3 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_4 fill:#ef5350,stroke:#333,color:#000
    style BDH1_5 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_6 fill:#ef5350,stroke:#333,color:#000
    style IRAKM_7 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_8 fill:#ef5350,stroke:#333,color:#000
    style OXCT1_9 fill:#ce93d8,stroke:#333,color:#000
    style metabolic_neuroscience_10 fill:#ef5350,stroke:#333,color:#000

3D Protein Structure

🧬 BDH1 — Search for structure Click to search RCSB PDB

🔍 Searching RCSB PDB for BDH1 structures...

Querying Protein Data Bank API

Source Analysis

What determines the optimal timing and dosing of ketogenic interventions for neuroprotection?

metabolic neuroscience | 2026-04-03 | completed

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)